Top Markets
#1 Trillions Trillions +4,371.22%
#2 Ozapay Ozapay +37.63%
#3 UnifAI Network UnifAI Network +26.77%
#4 Aria.AI Aria.AI +21.95%
#5 Zano Zano +17.34%
#6 Osaka Protocol Osaka Protocol +14.21%
#7 StakeStone StakeStone +13.94%
#8 Vestra DAO Vestra DAO +11.91%
#9 River Pts River Pts +10.84%
#10 pippin pippin +10.64%
Coin of the day
Trillions Trillions
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Rang in Aktien #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Aktienkurs
$0.28545656
Marktkapitalisierung
$4.50M
Veränderung (1 Tag)
5.97%
Veränderung (1 Jahr)
0.00%
Land
FR
Handel Acticor Biotech SAS (ALACT)

Kategorie

Healthcare
Kursverlauf für Acticor Biotech SAS (ALACT)
Höchster Schlusskurs: $0.29 am 2024-12-01

Niedrigster Schlusskurs: $7.56 am 2021-11-01
Kursverlauf der Aktie von Acticor Biotech SAS von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2024 -90.82%
2023 -58.62%
2022 31.92%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $36.74 -53.49%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $451.49 -11.91%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $737.00 9.61%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $297.72 51.37%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $94.95 -40.77%
AU